MDL | - |
---|---|
Molecular Weight | 1416.46 |
Molecular Formula | C63H83N17O14.C2HF3O2 |
SMILES | - |
Kisspeptin-10, human TFA is a potent vasoconstrictor and inhibitor of angiogenesis. Kisspeptin-10, human TFA acts as a tumor metastasis suppressor via its receptor GPR54. Kisspeptin-10-GPR54 system plays an important role in embryonic kidney development. Kisspeptin-10/GPR54 signaling induces osteoblast differentiation via NFATc4-mediated BMP2 expression [1] .
Kisspeptin-10 (KP-10) and its receptor GPR54 are key components in the regulation of GnRH secretion in humans and other mammals. Kisspeptin-10 protein binds to GPR54. Activation of Kisspeptin-10 suppresses pulmonary human melanoma and Kisspeptin-10 is a metastasis suppressor in breast cancer cells [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Intravenous infusion of kisspeptin-10 (7.5, 35, and 100 nM) induces a dose-dependent increase in LH secretion. The stimulatory effect of kisspeptin-10 (100 n nM) on LH secretion is blocked by the GnRH antagonist cetrorelix, precluding a singular action on gonadotropes [4] . Kisspeptin-10 inhibits angiogenesis in vivo . Kp-10 inhibits tumor growth in SCID mice xenografted with human prostate cancer cells (PC-3) through inhibiting tumor angiogenesis [5] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
Sealed storage, away from moisture
Powder | -80°C | 2 years |
---|---|---|
-20°C | 1 year |
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
DMSO : 100 mg/mL ( 70.60 mM ; Need ultrasonic)
H 2 O : 4 mg/mL ( 2.82 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 0.7060 mL | 3.5299 mL | 7.0599 mL |
5 mM | 0.1412 mL | 0.7060 mL | 1.4120 mL |
10 mM | 0.0706 mL | 0.3530 mL | 0.7060 mL |